OTCM
MSRM
, Last price
USD
Name
Mushrooms Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
167.68%
Rev. 5Y
-38.13%
Div Yld LY
—
Div Yld TTM
—
Revenues
2k
+143.51%
Net income
-25k
L+136.97%
CFO
1k
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Mushrooms, Inc. is a biotechnology company that develops products from mushrooms and mycelium. The company focuses on mycelium's industrial applications for carbon-neutral products, health supplements, and technologies for healthcare and textiles, such as bacterial detection and nutrient delivery. The company was formerly known as Marijuana Strategic Ventures Inc. and changed its name to Mushrooms Inc. in October 2022. [20, 22, 28, 33]
Key people
Phillip Malkemes
President, Director · since 2017
Director · since 2006
Danny Mack Mitchell
Vice President, Corporate Secretary, Director
Chief Executive Officer, Director · since 2017
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||